Compare MHK & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MHK | GKOS |
|---|---|---|
| Founded | 1988 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.0B |
| IPO Year | 1995 | 2015 |
| Metric | MHK | GKOS |
|---|---|---|
| Price | $112.60 | $129.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 12 |
| Target Price | $126.10 | ★ $126.92 |
| AVG Volume (30 Days) | 592.3K | ★ 1.3M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | N/A | ★ $507,442,000.00 |
| Revenue This Year | $3.38 | $23.32 |
| Revenue Next Year | $3.09 | $27.43 |
| P/E Ratio | $56.62 | ★ N/A |
| Revenue Growth | N/A | ★ 32.33 |
| 52 Week Low | $92.99 | $73.16 |
| 52 Week High | $143.13 | $148.11 |
| Indicator | MHK | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 60.41 | 55.91 |
| Support Level | $104.49 | $96.44 |
| Resistance Level | $115.00 | $130.23 |
| Average True Range (ATR) | 4.11 | 6.30 |
| MACD | 0.76 | 1.36 |
| Stochastic Oscillator | 79.54 | 92.55 |
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Global Ceramic designs, manufactures, sources, distributes and markets a broad line of ceramic, porcelain and natural stone tile products used for floor and wall applications in residential and commercial channels for both remodeling and new construction. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.